Literature DB >> 26415787

Encephalopathy with status epilepticus during sleep (ESES) induced by oxcarbazepine in idiopathic focal epilepsy in childhood.

Elena Pavlidis, Guido Rubboli, Marina Nikanorova, Margarethe Sophie Kölmel, Elena Gardella.   

Abstract

Encephalopathy with status epilepticus during sleep (ESES) is an age-related disorder characterized by neuropsychological regression, epilepsy and a typical EEG pattern of continuous epileptiform activity (> 85%) during NREM sleep. Cases of worsening or induction of ESES with phenytoin, carbamazepine and phenobarbital have been reported. We describe a child with benign epilepsy with centrotemporal spikes (BECTS) in whom treatment with oxcarbazepine (OXC) induced ESES. The patient was studied through repeated clinical-neuropsychological evaluations and 24-hour EEG recordings. He was treated with OXC two months after epilepsy onset. One month after starting OXC, he developed an abrupt and severe cognitive deterioration. A 24-hour EEG and neuropsychological tests showed an electroclinical picture compatible with ESES. Withdrawal of OXC and introduction of other drugs were followed by a prompt improvement. Five months after ESES onset, a 24-hour EEG was normal. Our report indicates that OXC can induce ESES in BECTS.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26415787      PMCID: PMC4610762          DOI: 10.11138/fneur/2015.30.2.139

Source DB:  PubMed          Journal:  Funct Neurol        ISSN: 0393-5264


  7 in total

1.  Seizure exacerbation associated with oxcarbazepine in idiopathic focal epilepsy of childhood.

Authors:  Kevin Chapman; Katherine Holland; Gerald Erenberg
Journal:  Neurology       Date:  2003-10-14       Impact factor: 9.910

2.  IFCN standards for digital recording of clinical EEG. International Federation of Clinical Neurophysiology.

Authors:  M R Nuwer; G Comi; R Emerson; A Fuglsang-Frederiksen; J M Guérit; H Hinrichs; A Ikeda; F J Luccas; P Rappelsburger
Journal:  Electroencephalogr Clin Neurophysiol       Date:  1998-03

3.  Levetiracetam or oxcarbazepine as monotherapy in newly diagnosed benign epilepsy of childhood with centrotemporal spikes (BECTS): an open-label, parallel group trial.

Authors:  Giangennaro Coppola; Emilio Franzoni; Alberto Verrotti; Caterina Garone; Jasenka Sarajlija; Francesca Felicia Operto; Antonio Pascotto
Journal:  Brain Dev       Date:  2006-10-20       Impact factor: 1.961

4.  Oxcarbazepine and atypical evolution of benign idiopathic focal epilepsy of childhood.

Authors:  S Grosso; M Balestri; R M Di Bartolo; L Corbini; G Vatti; P Curatolo; P Balestri
Journal:  Eur J Neurol       Date:  2006-10       Impact factor: 6.089

Review 5.  What is the evidence that oxcarbazepine and carbamazepine are distinctly different antiepileptic drugs?

Authors:  Dieter Schmidt; Christian E Elger
Journal:  Epilepsy Behav       Date:  2004-10       Impact factor: 2.937

6.  Encephalopathy with status epilepticus during sleep or continuous spikes and waves during slow sleep syndrome: a multicenter, long-term follow-up study of 117 patients.

Authors:  Roberto Horacio Caraballo; Pierangelo Veggiotti; María C Kaltenmeier; Elena Piazza; Beatriz Gamboni; María Francisca Lopez Avaria; Daniel Noli; Javier Adi; Ricardo Cersosimo
Journal:  Epilepsy Res       Date:  2013-03-16       Impact factor: 3.045

7.  Aggravation of seizures and/or EEG features in children treated with oxcarbazepine monotherapy.

Authors:  Martina Vendrame; Divya S Khurana; Marcos Cruz; Joseph Melvin; Ignacio Valencia; Agustin Legido; Sanjeev V Kothare
Journal:  Epilepsia       Date:  2007-07-21       Impact factor: 5.864

  7 in total
  2 in total

1.  Treatment Practices and Outcomes in Continuous Spike and Wave during Slow Wave Sleep: A Multicenter Collaboration.

Authors:  Fiona M Baumer; Nancy A McNamara; Anthony L Fine; Elia Pestana-Knight; Renée A Shellhaas; Zihuai He; Daniel H Arndt; William D Gaillard; Sarah A Kelley; Margot Nagan; Adam P Ostendorf; Nilika S Singhal; Laura Speltz; Kevin E Chapman
Journal:  J Pediatr       Date:  2021-01-20       Impact factor: 4.406

2.  Expression of Multidrug Resistance Genes in Peripheral Blood of Patients with Refractory Epilepsy and the Reverse Effect of Oxcarbazepine on Its Expression.

Authors:  Jinming Ji; Gang Li; Yunxia Ma; Shuangshuang Pan; Rongrong Yuan
Journal:  Iran J Public Health       Date:  2018-01       Impact factor: 1.429

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.